Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

NCT03575520 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pegfilgrastim
DRUG: Doxorubicin/Cyclophosphamide(AC) treatment

Sponsor

Yonsei University